skip to main content
Give

New CPRIT Grant for Drug Discovery Resource Center

Announcement: New CPRIT Grant Awarded to Texas A&M Health Science Center’s High-throughput Screening Center to Establish the Drug Discovery Resource Center (DDRC, RP250505)

The High-throughput Screening Center at the Institute of Bioscience and Technology at TMC3 Collaborative Research Building Campus, RRID: SCR_022214, is proud to announce the receipt of a new grant from the Cancer Prevention and Research Institute of Texas (CPRIT), grant number RP250505. This funding strengthens our mission to accelerate the discovery of novel drugs and treatments for devastating cancers, serving as a vital resource for researchers across Texas and beyond.

Located in the heart of the Texas Medical Center, our program provides access to state-of-the-art tools and expertise, supporting scientists from Texas A&M University, the Houston/Galveston region, and pharmaceutical and biotechnology partners. The CPRIT grant RP250505 enhances our capabilities, enabling innovative high-throughput screening and drug discovery projects to address unmet needs in cancer treatment.

Program Highlights and Benefits

The Drug Discovery Resource Center Program offers:

  • Advanced Infrastructure: Automated systems for biochemical and cell-based high-throughput screens to identify promising therapeutic candidates.
  • Extensive Compound Library: A collection of nearly 50,000 drugs and small molecules, including FDA-approved clinical candidates, off-patent drugs, natural products, and pathway-specific modulators for mechanism-of-action studies and target discovery.
  • Expert Multidisciplinary Team: Our staff includes biologists, biochemists, medicinal chemists, pharmacologists, and informaticians with extensive industry and academic experience. We form customized project teams to support assay development, screening, and data analysis, ensuring tailored solutions for each investigator.
  • Collaborative Approach: We foster partnerships with academic and industry researchers to deliver integrated, impactful drug discovery programs.

This CPRIT grant (RP250505) will further our efforts to develop new therapeutic strategies, leveraging our cutting-edge AI-driven resources to translate discoveries from the laboratory to the clinic, ultimately improving outcomes for cancer patients.

Acknowledgment and Terms

By utilizing the High Throughput Research and Drug Discovery Screening Core, RRID: SCR_022214, supported by CPRIT grant RP250505, users agree to the following:

Please acknowledge the CPRIT grant number RP250505 and our Research Resource ID RRID: SCR_022214 in all resulting publications, presentations, or reports. Include the grant number in an acknowledgment section, such as: “This work was supported by the Cancer Prevention and Research Institute of Texas (CPRIT) grant RP250505 and the High Throughput Research and Drug Discovery Screening Core (RRID: SCR_022214).”

Users must comply with applicable laws, adhere to data-sharing policies, and properly acknowledge the core’s contributions. This disclaimer may be updated, and users are responsible for staying informed. For questions or concerns, please contact the program at [insert contact information].

About CPRIT

Established by Texas voters in 2007, the Cancer Prevention and Research Institute of Texas (CPRIT) is a $6 billion initiative to fund innovative cancer research and prevention programs. CPRIT’s merit-based, peer-reviewed grants support groundbreaking projects across Texas, positioning the state as a leader in the fight against cancer.

We are grateful for CPRIT’s support and look forward to advancing cancer research through this transformative grant. For more information about the Drug Discovery Resource Center Program or to collaborate, please visit [insert program website] or contact our team.